Latest Insider Transactions at Inmune Bio, Inc. (INMB)
This section provides a real-time view of insider transactions for Inmune Bio, Inc. (INMB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inmune Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inmune Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
David J Moss Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.77%
|
$50,000
$5.29 P/Share
|
|
Sep 12
2024
|
David J Moss Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,690
+0.6%
|
$46,140
$6.38 P/Share
|
|
Sep 12
2024
|
Raymond Joseph Tesi President and CEO |
BUY
Open market or private purchase
|
Direct |
15,380
+0.98%
|
$92,280
$6.38 P/Share
|
|
Jun 25
2024
|
Scott Juda Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+6.53%
|
$35,000
$7.27 P/Share
|
|
Apr 19
2024
|
Mark William Lowdell Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,423
+0.95%
|
$115,384
$8.32 P/Share
|
|
Apr 19
2024
|
David J Moss Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,028
+1.4%
|
$144,224
$8.32 P/Share
|
|
Apr 19
2024
|
Raymond Joseph Tesi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,028
+1.16%
|
$144,224
$8.32 P/Share
|
|
Apr 19
2024
|
Scott Juda Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,603
+30.77%
|
$236,824
$8.32 P/Share
|
|
Nov 10
2023
|
Scott Juda Director |
BUY
Open market or private purchase
|
Indirect |
7,000
+15.91%
|
$42,000
$6.95 P/Share
|
|
Jul 12
2023
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
10,000
-10.85%
|
$110,000
$11.01 P/Share
|
|
Mar 17
2023
|
David J Moss Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+0.2%
|
$15,000
$6.42 P/Share
|
|
May 27
2022
|
David J Moss Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.24%
|
$18,000
$6.79 P/Share
|
|
May 26
2022
|
David J Moss Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,700
+0.61%
|
$46,200
$6.27 P/Share
|
|
May 26
2022
|
Raymond Joseph Tesi President and CEO |
BUY
Open market or private purchase
|
Direct |
6,300
+0.41%
|
$37,800
$6.41 P/Share
|
|
Mar 22
2022
|
James Kelly Ganjei Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,793
+50.0%
|
$142,344
$8.43 P/Share
|
|
Mar 22
2022
|
David J Moss Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,793
+1.42%
|
$142,344
$8.43 P/Share
|
|
Mar 22
2022
|
Raymond Joseph Tesi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,724
+1.54%
|
$189,792
$8.43 P/Share
|
|
Mar 22
2022
|
Mark William Lowdell Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,590
+1.55%
|
$188,720
$8.43 P/Share
|
|
Nov 17
2021
|
Scott Juda Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+7.69%
|
$32,500
$13.55 P/Share
|
|
Nov 03
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
3,626
-0.24%
|
$72,520
$20.0 P/Share
|
|
Nov 03
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,025
-0.08%
|
$20,500
$20.0 P/Share
|
|
Nov 03
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
701
-0.05%
|
$14,020
$20.0 P/Share
|
|
Oct 27
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,079
-0.17%
|
$41,580
$20.0 P/Share
|
|
Oct 27
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,357
-0.16%
|
$47,140
$20.0 P/Share
|
|
Oct 27
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
6,517
-0.43%
|
$130,340
$20.0 P/Share
|
|
Oct 25
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13
-0.0%
|
$260
$20.0 P/Share
|
|
Oct 22
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
400
-0.03%
|
$8,000
$20.0 P/Share
|
|
Oct 22
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,142
-0.09%
|
$22,840
$20.0 P/Share
|
|
Oct 22
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
23,616
-1.55%
|
$472,320
$20.0 P/Share
|
|
Sep 03
2021
|
Xencor Inc |
BUY
Exercise of conversion of derivative security
|
Direct |
108,000
+5.42%
|
$756,000
$7.8 P/Share
|
|
Aug 25
2021
|
Raymond Joseph Tesi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+1.93%
|
$90,000
$3.91 P/Share
|
|
Jul 16
2021
|
David J Moss Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.0%
|
$75,000
$3.91 P/Share
|
|
Jul 13
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
14,480
-13.58%
|
$390,960
$27.63 P/Share
|
|
Jul 09
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
30,000
-21.95%
|
$690,000
$23.2 P/Share
|
|
Jul 08
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
24,351
-1.59%
|
$487,020
$20.08 P/Share
|
|
Jul 08
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,302
-1.34%
|
$326,040
$20.09 P/Share
|
|
Jul 08
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
24,150
-1.61%
|
$483,000
$20.19 P/Share
|
|
Jul 07
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
5,649
-0.37%
|
$112,980
$20.02 P/Share
|
|
Jul 07
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,698
-0.71%
|
$173,960
$20.01 P/Share
|
|
Jul 07
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,850
-0.39%
|
$117,000
$20.02 P/Share
|
|
Jun 14
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
10,000
-6.82%
|
$190,000
$19.02 P/Share
|
|
Jun 10
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
10,000
-6.38%
|
$170,000
$17.01 P/Share
|
|
Jun 10
2021
|
Xencor Inc |
BUY
Other acquisition or disposition
|
Direct |
192,532
+9.77%
|
$3,273,044
$17.14 P/Share
|
|
Mar 31
2021
|
Timothy J Schroeder Director |
SELL
Open market or private sale
|
Indirect |
10,000
-6.0%
|
$110,000
$11.95 P/Share
|